Going the distance.

THAT’S OUR TARGET

By activating the immune system within the tumor, the road ahead for patients is paved with possibility.

Learn More

Transforming Immunity. Restoring Hope.

We’re devoted to redefining the treatment of cancer and rare diseases where serious unmet needs exist.

Learn More

Meaningful Treatments.

We’re committed to investigating new medicines that have the potential to improve lives.

Learn More

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.

News

Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma

– Objective Response Rate Endpoint Not Met – EXTON, Pa. , March 18, 2021 (GLOBE NEWSWIRE) --… Read more 

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

ILLUMINATE-301 Continues on Track for Data Later this Month EXTON, Pa. , March 01, 2021 (GLOBE… Read more 

Idera Pharmaceuticals to Present at Upcoming Conferences

EXTON, Pa. , Jan. 11, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today… Read more 

Learn More